HOME >> MEDICINE >> NEWS
'Biochemical storm' following brain trauma, an important factor in treatment

ins. Automobile crashes, gunshot wounds, sporting accidents and other incidents cause an estimated 52,000 brain injury deaths each year in the United States, according to the National Institutes of Health. An additional 70,000 people -- with men outnumbering women 2 to 1 -- suffer a blow that results in substantial ongoing difficulties with communication tasks, coordination, memory and thinking. An estimated 5.3 million people are permanently disabled.

Because of the lasting consequences of brain damage, lifetime costs for care and rehabilitation for a person with a severe injury range from $600,000 to $1.9 million, according to NIH. Hayes and Brian Pike, an assistant professor of neuroscience, conducted their experiments with colleagues at the University of Texas Medical School before transferring their efforts to UF this past summer. The experiments showed that calpains switch on when calcium floods cells after traumatic brain injury. The activation of the calpains is associated with the death of brain cells and could contribute to the extensive atrophy and shrinkage of the brain seen after traumatic injury.

"In the past several years, there have been a large number of clinical trials testing treatments for brain injury that have shown no effect," said Hayes, a professor of neuroscience in UF's College of Medicine. "Researchers thought they had an effective therapy, but when they tried it, the people didn't get better. One reason may be that they didn't treat the patient long enough because the biochemical storm lasted longer than two days." To complicate matters, some level of calpain activity may actually be a necessary part of a "resculpting" effort that can repair damage.

"We may have to completely redefine our approach to therapy, because if you try to get in there too early and for too brief a time with a treatment, you might not block the damage that lies ahead," Hayes said. "But if you give a treatment for too long, you might block some of th
'"/>

Contact: Victoria White
vickiwhite@xtalwind.net
352-344-2738
University of Florida
27-Oct-1999


Page: 1 2 3

Related medicine news :

1. US FDA grants full approval to DOXIL(R) following submission of phase III data
2. Patients with abdominal trauma at risk for intra-abdominal infections following surgery
3. Guidelines for following pediatric cancer survivors aim to reduce medical complications
4. Can the standard course of radiation therapy following lumpectomy be shortened?
5. Higher incidence of rejection following early steroid withdrawal
6. Impaired neuromotor function following cancer treatment can improve
7. Significant pain relief following gastric bypass surgery
8. Carbon monoxide from smoking helps keep arteries open following angioplasty
9. CellCept associated with reduced incidence of cancer, compared to AZA, following heart transplant
10. Study shows lower than expected allergic-like events following second prescription of penicillin
11. Hospitals following heart attack guidelines have better outcomes

Post Your Comments:
(Date:5/18/2013)... ROCHESTER, Minn. -- Regular consumption of coffee is ... cholangitis (PSC), an autoimmune liver disease, Mayo Clinic ... the Digestive Disease Week 2013 conference in Orlando, ... of the bile ducts that results in inflammation ... of the liver, liver failure and biliary cancer. ...
(Date:5/18/2013)... Utah (PRWEB) May 18, 2013 ... on insurance agents’ role in Marketplaces . ... to traditional employer sponsored health benefits, is the ... and health reimbursement arrangements . , ... Health and Human Services (HHS) recently released a ...
(Date:5/18/2013)... The “World Healthcare IT Market: Trends & ... market drivers, restraints, and opportunities in North America, Europe, ... 89 market data tables , ... IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , ... The global healthcare IT market is expected to grow ...
(Date:5/18/2013)... 18, 2013 As metal-on-metal hip ... the country, Bernstein Liebhard LLP notes that a new ... suffer tissue damage before they experience any pain from ... Science Daily will appear in the Journal of Bone ... MRI screens of their hips. The researchers found ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices ... Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user ... studies the major market drivers, restraints, and opportunities in ... , Browse , 147 market ... , 318 pagesand in-depth TOC of ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation (NYSE: ... the annual EuroPCR Scientific Program May 21-24 in ... to present a particularly rich and diversified set of ... Dawkins , M.D., global chief medical officer, Boston ... be presented, including the NG PROMUS trial, which evaluated ...
(Date:5/16/2013)...  PTC Therapeutics, Inc., today announced that it has ... U.S. Securities and Exchange Commission ("SEC") relating to the ... number of shares to be offered and the price ... (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) J.P. ... managers for the offering. Cowen and Company is acting ...
(Date:5/16/2013)... and SYDNEY , May 16, 2013 /PRNewswire/ ... HIN), a leading innovator of less invasive, miniaturized circulatory support ... today announced that CEO Doug Godshall ... Conference at 11:00 a.m. EDT on Monday, May 20, 2013.  ... Sheraton New York Hotel. A live webcast of ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
Cached News: